-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on GeneDx Holdings, Maintains $90 Price Target

Benzinga·08/04/2026 09:15:14
語音播報
BTIG analyst Mark Massaro reiterates GeneDx Holdings (NASDAQ:WGS) with a Buy and maintains $90 price target.